Science, engineering and technology continue to impact and guide our futures through the rapidly expanding bioeconomy – helping us to stay healthy, feed our growing population, produce enough energy and live sustainably on our fragile planet.
| Networking/Refreshments | 08:15 – 09:00 | Registration and Coffee |
| Networking/Refreshments | 09:00 – 09:15 | Welcome Professors Richard Kitney and Paul Freemont, Co-Directors, SynbiCITE Lord David Willetts, Executive Chair, Resolution Foundation |
| Keynote | 09:15 – 10:00 | Keynote: Designing biology at scale Jason Kelly, CEO, Ginkgo Bioworks Ginkgo is passionate about engineering biology. We use the power of biology to build sustainable products in food, pharma, manufacturing, and more on a global scale. |
| Panel discussions | 10:00 – 10:45 | Panel Discussion: Growing the Bioeconomy Introduced and chaired by Lionel Clarke, Co-chair, Synthetic Biology Leadership Council
The successful use of synthetic biology innovation requires industrial strategy and policies that support manufacturing at scale to solve global challenges; hear from leading policymakers and industry influencers on how the UK is striding ahead in growing the global bioeconomy. |
| Networking/Refreshments | 10:45 – 11:15 | Coffee Break |
| Presentations | 11:15 – 12:30 | Company Presentations: Accelerating bioscience Chair: Dr Liz Fletcher, Manager, UK Centre for Mammalian Synthetic Biology Multinational speaker: SME / Start-up speakers:
Hear how world-leading UK companies are innovating to create DNA by the kilogramme using AI-driven integrated machines, alongside customised 'systems thinking' technology, for automated manufacturing systems |
| Networking/Refreshments | 12:30 – 13:30 | Lunch |
| Panel discussions | 13:30 – 14:15 | Panel Discussion: Technology & Innovation Introduced and Chaired by Rick Johnson, CEO, Global Helix LLC
Raising industry and public awareness of industrialised synthetic biology is all important and requires clear and current thinking to maintain the best interests of society at its core; experts from across the industry, responsible innovation practitioners and policymakers discuss how this is being done better than you might be aware |
| Keynote | 14:15 – 14:45 | Keynote: Emerging Investment Trends in the Synthetic Biology Industry John Cumbers, Founder, SynBioBeta
|
| Panel discussions | 14:45 – 15:30 | Panel Discussion: How might we best develop synthetic biology with and for society? Chaired by Sir Roland Jackson, Research Associate, UCL
|
| Networking/Refreshments | 15:30 – 16:00 | Tea Break |
| Keynote | 16:00 – 16:30 | Synbio Unplugged: In conversation with Hagan Bayley Hagan Bayley, Co-Founder, Oxford Nanopore Technologies Interviewed by Carly Minsky, Senior Reporter, Sifted |
| Presentations | 16:30 – 17:45 | Company Presentations: Making a material difference to the planet Chair: Dr Kirk Malone, Director of Commercialisation, Manchester Institute of Biotechnology Multinational speaker: SME / Start-up speakers:
Biomanufacturing at scale can create materials that will make an enormous difference to preserving our environment and furthering sustainability, with implications ranging from reducing man-made climate change effects, to reprocessing waste into useful materials and energy. Hear from leaders in the field about how they biomanufacture at scale, the novel processes and equipment they use and the accelerating business growth they achieve as a result |
| Keynote | 17:45 – 18:15 | Synbio Unplugged: In conversation with Lord David Willetts Lord David Willetts, Executive Chair, Resolution Foundation Interviewed by Lyndsey Jones, Executive editor & Section chief, Day Production, Financial Times |
| Networking/Refreshments | 18:15 – 20:00 | Sponsored Champagne and Networking |
| Networking/Refreshments | 08:00 – 08:30 | Arrival and Coffee |
| Keynote | 08:30 – 09:10 | Policy Presentations: Growing the bioeconomy - solving global challenges
The global bioeconomy is driven by policy supporting industrial strategy; hear from leading global policymakers how they are supporting synthetic biology strategy, policy and the regulatory environment, their agenda for growth and what’s coming next for synthetic biology |
| Keynote | 09:10 – 09:30 | Plenary: Twist Bioscience Rebecca Nugent, Director, Synthetic Biology Research, Twist Bioscience |
| Keynote | 09:30 – 10:00 | Keynote: How did we get here and where are we going? Claire Bergkamp, Sustainability & Innovation Director, Stella McCartney |
| Panel discussions | 10:00 – 10:45 | Panel Discussion: How to dress the world better: Bio-design and fashion Chair: Helene Steiner, Director & Co-Founder Open Cell Panel:
Synthetic biology innovation can create new, sustainable fabrics, dyes and materials for the fashion industry, hugely impacting global resource use. These include spider silk, mushroom leather and reprocessed plastics. Hear from leaders in sustainability and innovation, from brands such as Stella McCartney, Vogue, Pili, Colorifix, who are redesigning the future of fashion using the newest advances and innovation in synthetic biology |
| Networking/Refreshments | 10:45 – 11:15 | Coffee Break |
| Presentations | 11:15 – 12:30 | Company Presentations: The synbio effect on healthcare Multinational speaker: SME / Start-up speakers:
Synthetic biology is transforming healthcare – from the design of new vaccine platforms, to manufacturing DNA by the kg, to personalised treatments based on diagnostics never before possible without synthetic biology. Hear from global leaders and innovators in synthetic biology about their new vaccine platforms, cancer and heart disease treatments, diagnostic tools and microbiome therapeutics |
| Networking/Refreshments | 12:30 – 13:30 | Lunch |
| Panel discussions | 13:30 – 14:15 | Panel Discussion: High impact investment opportunities in synthetic biology Chair: Mike Ward, Chief Content Officer, Informa Pharma Intelligence Insights Portfolio
Global investment in synthetic biology companies in 2018 reached a record high of £3.2 billion. In 2019 the outlook is very positive, with £520 million raised in the first quarter alone according to figures from SynBioBeta. Hear from investors in UK and US synthetic biology companies about just how good this outlook is and why everyone should consider investing in synthetic biology start-ups and SMEs |
| Presentations | 14:15 – 15:45 | Company Presentations: Food and new technology for a healthy and sustainable world Chair: Dr Dieuwertje van der Does, Programme Manager, OpenPlant Synthetic Biology Research Centre Multinational speaker: SME / Start-up speakers:
|
| Networking/Refreshments | 15:45 – 16:10 | Tea Break |
| Presentations | 16:10 – 17:00 | Company Presentations: Materials, Chemicals and Therapeutics for a Healthy and Sustainable World Chair: Dr Ros Le Feuvre, Director of Operations, SYNBIOCHEM and FBRH SME / Start-up speakers:
From cleaning water of toxins to creating new proteins, new therapeutics and sustainably generated products, hear from start-ups changing the face of global sustainability using innovation ranging from AI to automation in synthetic biology R&D and manufacturing |
| Keynote | 17:00 – 17:30 | Synbio Unplugged: In conversation with Hermann Hauser Hermann Hauser, Co-founder and Venture Partner, Amadeus Capital Partners Interviewed by Mike Ward, Chief Content Officer, Informa Pharma Intelligence Insights Portfolio |
| Panel discussions | 17:30 – 18:00 | Biodesign: moving beyond discovery
Hear from leading-lights in biodesign on how they are redesigning our futures using the power and utility of organisms and their natural interaction with larger and ever-changing ecosystems around us, from cell-free technologies to AI derived proteins |
| Networking/Refreshments | 18:00 – 20:00 | Closing reception and networking |
